| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |